These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 6773414

  • 1. Insulin resistance: definition and treatment.
    Roffman DS, Wiser TH.
    Am J Hosp Pharm; 1980 Aug; 37(8):1105-10. PubMed ID: 6773414
    [Abstract] [Full Text] [Related]

  • 2. [New data in the domain of insulin resistance].
    Freychet P.
    Sem Hop; 1977 Jun 23; 53(24):1421-4. PubMed ID: 197631
    [Abstract] [Full Text] [Related]

  • 3. [Progress in the therapy of diabetes].
    Raptis S, Rothenbuchner G, Pfeiffer EF.
    Wien Med Wochenschr; 1971 Apr 03; 121(14):261-9. PubMed ID: 5559791
    [No Abstract] [Full Text] [Related]

  • 4. Management of insulin allergy and resistance.
    Elenbaas RM, Forni PJ.
    Am J Hosp Pharm; 1976 May 03; 33(5):491-7. PubMed ID: 1274964
    [Abstract] [Full Text] [Related]

  • 5. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E, Minuto F, Colao A, Ferone D.
    Acta Diabetol; 2009 Jun 03; 46(2):85-95. PubMed ID: 19322513
    [Abstract] [Full Text] [Related]

  • 6. [Role of oral hypoglycemic agents in the therapeutic approach to diabetic obesity].
    Albert J, Ekoé JM.
    Sem Hop; 1983 Sep 01; 59(29-30):2135-40. PubMed ID: 6312587
    [Abstract] [Full Text] [Related]

  • 7. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
    Stefanović V, Antić S.
    Clin Lab; 2004 Sep 01; 50(5-6):271-8. PubMed ID: 15209435
    [Abstract] [Full Text] [Related]

  • 8. [General immunologic complications of insulin therapy].
    Scapellato L.
    Recenti Prog Med; 1973 Dec 01; 55(6):527-64. PubMed ID: 4131078
    [No Abstract] [Full Text] [Related]

  • 9. [The use of human insulin in 3 patients with diabetes mellitus and insulin resistance].
    Khristov V, Manov A.
    Vutr Boles; 1989 Dec 01; 28(1):51-6. PubMed ID: 2662609
    [Abstract] [Full Text] [Related]

  • 10. Insulin resistance and new insulins.
    Yue DK, Turtle JR.
    Aust Fam Physician; 1977 Mar 01; 6(3):286, 289. PubMed ID: 869782
    [Abstract] [Full Text] [Related]

  • 11. Promising new approaches.
    Reasner CA.
    Diabetes Obes Metab; 1999 May 01; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [Abstract] [Full Text] [Related]

  • 12. Combinations of oral hypoglycemic drugs in obese, insulin-resistant diabetics.
    Fineberg SK.
    Geriatrics; 1968 Sep 01; 23(9):137-46. PubMed ID: 5673663
    [No Abstract] [Full Text] [Related]

  • 13. Failure of insulin treatment in obese patients with non-insulin-dependent diabetes mellitus.
    Fassberg J, Toffler WL, Fields SA, Loriaux LD.
    J Fam Pract; 1993 Jul 01; 37(1):76-81. PubMed ID: 8345343
    [Abstract] [Full Text] [Related]

  • 14. [Diagnostic and therapeutic problems in patients with insulin resistence].
    Grüneklee D, Takaishi T, Daweke H.
    Munch Med Wochenschr; 1970 Jul 03; 112(27):1278-86. PubMed ID: 5467940
    [No Abstract] [Full Text] [Related]

  • 15. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE, Calderara A, Pacchioni M, Cassisa C, Pozza G.
    Diabete Metab; 1993 Jul 03; 19(1):30-5. PubMed ID: 8504882
    [Abstract] [Full Text] [Related]

  • 16. Insulin resistant diabetes mellitus without the presence of insulin antibodies. A case report.
    Páv J, Srámková J, Matys Z.
    Endokrinologie; 1976 Jul 03; 67(3):373-6. PubMed ID: 976212
    [Abstract] [Full Text] [Related]

  • 17. Immunologic sensitization of circulating basophils to exogenous insulin in diabetic patients.
    Emanuelli G, Gatti G, Calcamuggi G, Anfossi G, Cotto A, Marcarino C, Camussi G, Ottone G.
    Panminerva Med; 1981 Jul 03; 23(2):81-8. PubMed ID: 7033894
    [No Abstract] [Full Text] [Related]

  • 18. Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.
    Darmon P, Curtillet C, Boullu S, Laugier A, Dutour A, Oliver C.
    Diabetes Care; 1998 Sep 03; 21(9):1575. PubMed ID: 9727917
    [No Abstract] [Full Text] [Related]

  • 19. Treatment with chlorpropamide-phenformin combination in adult, obese, ketosis-resistant diabetics.
    Lev-Ran AS.
    Isr J Med Sci; 1971 Jun 03; 7(6):727-32. PubMed ID: 4997820
    [No Abstract] [Full Text] [Related]

  • 20. Insulin antibodies and the control of diabetes.
    Dixon K, Exon PD, Malins JM.
    Q J Med; 1975 Oct 03; 44(176):543-53. PubMed ID: 1105646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.